Am­gen's CEO says he's 'con­fi­den­t' their $28B deal with Hori­zon can close de­spite FTC law­suit

A day af­ter fed­er­al an­titrust au­thor­i­ties sued to stop Am­gen’s $28 bil­lion takeover of Hori­zon Ther­a­peu­tics, Am­gen’s CEO said he still ex­pects the deal to close.

“We re­main ex­cit­ed about the prospect of this com­bi­na­tion,” Am­gen CEO Robert Brad­way said at an event host­ed by the Fi­nan­cial Times on Wednes­day in New York. (The FT owns a ma­jor­i­ty stake in End­points News, though the news or­ga­ni­za­tions are in­de­pen­dent.)

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER